Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT06551220
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer with Different HER2 Expression Patterns
800 Enrollment(s)
23 Study location(s)
OBSERVATIONAL (None)
Metastatic Breast Cancer
COMPLETED
NCT05246514
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
72 Enrollment(s)
28 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-mutant Non-Small Cell Lung Cancer
NOT_YET_RECRUITING
NCT06711978
Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors
66 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
CIPN


CIPN - Chemotherapy-Induced Peripheral Neuropathy


CIPN in Adjuvant Breast Cancer Patients


Duloxetine


Mirogabalin
RECRUITING
NCT04635111
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
30 Enrollment(s)
8 Study location(s)
OBSERVATIONAL (None)
Hepatotoxicity


Tenosynovial Giant Cell Tumor
NOT_YET_RECRUITING
NCT06608472
Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension
292 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Essential Arterial Hypertension
RECRUITING
NCT06172127
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
165 Enrollment(s)
20 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-positive Breast Cancer
RECRUITING
NCT06102824
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
252 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-negative Breast Cancer


Advanced Breast Cancer
RECRUITING
NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
358 Enrollment(s)
11 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Tumor


Metastatic Solid Tumor


Soft Tissue Sarcoma (STS)


Platinum-resistant Ovarian Cancer (PROC)


Hepatocellular Carcinoma (HCC)


Colorectal Cancer (CRC)


HER2 Negative Breast Cancer


Cutaneous Melanoma


Renal Cell Carcinoma (RCC)